Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Mallinckrodt
Johnson and Johnson
Fish and Richardson
QuintilesIMS
Daiichi Sankyo
Boehringer Ingelheim
Dow
US Army

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,689,333

« Back to Dashboard

Summary for Patent: 4,689,333

Title: 2-(2-pyridylmethylthio (sulfinyl)) benzimidazoles
Abstract:The compound of the formula ##STR1## wherein R.sup.1 is hydrogen, methoxy or trifluoromethyl, R.sup.2 and R.sup.3 are independently hydrogen or methyl, R.sup.4 is a C.sub.2-5 fluorinated alkyl and n denotes 0 or 1, or a pharmacologically acceptable salt thereof is novel, and useful for prophylaxis and therapy of digestive ulcers (e.g. gastric ulcer, duodenal ulcer) and gastritis.
Inventor(s): Nohara; Akira (Kyoto, JP), Maki; Yoshitaka (Kyoto, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:06/937,193
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,689,333

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan59-171069Aug 16, 1984

International Patent Family for Patent: 4,689,333

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Lithuania2118► Subscribe
Germany19975020► Subscribe
Denmark356485► Subscribe
Denmark171340► Subscribe
European Patent Office0174726► SubscribeSPC/GB94/011United Kingdom► Subscribe
European Patent Office0174726► Subscribe93C0021Belgium► Subscribe
Spain546152► Subscribe
Spain8607288► Subscribe
Greece851981► Subscribe
Hong Kong4792► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Merck
UBS
Daiichi Sankyo
Accenture
Dow
Chinese Patent Office
Harvard Business School
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot